My Quote Request
No products added yet
6505-01-226-5517
20 Products
Y-102
IOHEXOL INJECTION,USP
NSN, MFG P/N
6505012265517
NSN
6505-01-226-5517
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 180.000 MILLIGRAMS IODINE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOHEXOL AND TROMETHAMINE 20ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 20
Related Searches:
NDC00074-6304-11
ERYTHROMYCIN TABLETS,USP
NSN, MFG P/N
6505012259498
NSN
6505-01-225-9498
NDC00074-6304-11
ERYTHROMYCIN TABLETS,USP
NSN, MFG P/N
6505012259498
NSN
6505-01-225-9498
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED AND ENTERIC COATED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
THERAPEUTIC EQUIVALENT: ABBOTT LABS. HOSP. PRODS. DIV.
Related Searches:
NDC00524-0207-21
ERYTHROMYCIN TABLETS,USP
NSN, MFG P/N
6505012259498
NSN
6505-01-225-9498
NDC00524-0207-21
ERYTHROMYCIN TABLETS,USP
NSN, MFG P/N
6505012259498
NSN
6505-01-225-9498
MFG
BOOTS PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 250.000 MILLIGRAMS ERYTHROMYCIN ACTIVE INGREDIENT
FEATURES PROVIDED: INDIVIDUALLY SEALED AND ENTERIC COATED
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: STRIP
THERAPEUTIC EQUIVALENT: ABBOTT LABS. HOSP. PRODS. DIV.
Related Searches:
NDC52769-0574-11
VARICELLA-ZOSTER IMMUNE GLOBULIN,USP
NSN, MFG P/N
6505012259730
NSN
6505-01-225-9730
NDC52769-0574-11
VARICELLA-ZOSTER IMMUNE GLOBULIN,USP
NSN, MFG P/N
6505012259730
NSN
6505-01-225-9730
MFG
FFF ENTERPRISES INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VARICELLA-ZOSTER IMMUNE GLOBULIN USP 125UN PER VIAL
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 125.000 UNITS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 2 ML OR LESS
Related Searches:
VZIG
VARICELLA-ZOSTER IMMUNE GLOBULIN,USP
NSN, MFG P/N
6505012259730
NSN
6505-01-225-9730
VZIG
VARICELLA-ZOSTER IMMUNE GLOBULIN,USP
NSN, MFG P/N
6505012259730
NSN
6505-01-225-9730
MFG
FFF ENTERPRISES INC
Description
III PART NAME ASSIGNED BY CONTROLLING AGENCY: VARICELLA-ZOSTER IMMUNE GLOBULIN USP 125UN PER VIAL
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS AND SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 125.000 UNITS
PRIMARY CONTAINER TYPE: VIAL
SPECIAL FEATURES: 2 ML OR LESS
Related Searches:
FLORICAL
SODIUM FLUORIDE AND CALCIUM CARBONATE CAPSULES
NSN, MFG P/N
6505012259731
NSN
6505-01-225-9731
FLORICAL
SODIUM FLUORIDE AND CALCIUM CARBONATE CAPSULES
NSN, MFG P/N
6505012259731
NSN
6505-01-225-9731
MFG
MERICON INDUSTRIES INC
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM FLUORIDE AND CALCIUM CARBONATE CAPSULES 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 8.300 MG SODIUM FLUORIDE AND 364.000 MG CALCIUM CARBONATE
Related Searches:
FLORICAL CAPSULES
SODIUM FLUORIDE AND CALCIUM CARBONATE CAPSULES
NSN, MFG P/N
6505012259731
NSN
6505-01-225-9731
FLORICAL CAPSULES
SODIUM FLUORIDE AND CALCIUM CARBONATE CAPSULES
NSN, MFG P/N
6505012259731
NSN
6505-01-225-9731
MFG
MERICON INDUSTRIES INC
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM FLUORIDE AND CALCIUM CARBONATE CAPSULES 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 8.300 MG SODIUM FLUORIDE AND 364.000 MG CALCIUM CARBONATE
Related Searches:
NDC00394-0102-02
SODIUM FLUORIDE AND CALCIUM CARBONATE CAPSULES
NSN, MFG P/N
6505012259731
NSN
6505-01-225-9731
NDC00394-0102-02
SODIUM FLUORIDE AND CALCIUM CARBONATE CAPSULES
NSN, MFG P/N
6505012259731
NSN
6505-01-225-9731
MFG
MERICON INDUSTRIES INC
Description
CAPSULE CONTENT FORM: ANY ACCEPTABLE
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: ANY ACCEPTABLE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: SODIUM FLUORIDE AND CALCIUM CARBONATE CAPSULES 100S BT
PRIMARY CONTAINER TYPE: BOTTLE
SPECIAL FEATURES: 8.300 MG SODIUM FLUORIDE AND 364.000 MG CALCIUM CARBONATE
Related Searches:
NDC00071-0100-32
CHLORPROMAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012261635
NSN
6505-01-226-1635
NDC00071-0100-32
CHLORPROMAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012261635
NSN
6505-01-226-1635
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS CHLORPROMAZINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: PARKE-DAVIS DIV.
Related Searches:
PROMAPAR
CHLORPROMAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012261635
NSN
6505-01-226-1635
PROMAPAR
CHLORPROMAZINE HYDROCHLORIDE TABLETS,USP
NSN, MFG P/N
6505012261635
NSN
6505-01-226-1635
MFG
PARKE-DAVIS DIV OF WARNER-LAMBERT CO
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 MILLIGRAMS CHLORPROMAZINE HYDROCHLORIDE ACTIVE INGREDIENT
PRIMARY CONTAINER CONTENT QUANTITY: 1000.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
THERAPEUTIC EQUIVALENT: PARKE-DAVIS DIV.
Related Searches:
NDC00003-0450-54
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505012262924
NSN
6505-01-226-2924
NDC00003-0450-54
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505012262924
NSN
6505-01-226-2924
MFG
PAR PHARMACEUTICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 12.500 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL TABLETS USP 12.5MG 100S PER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00093-0091-01
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505012262924
NSN
6505-01-226-2924
NDC00093-0091-01
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505012262924
NSN
6505-01-226-2924
MFG
TEVA PHARMACEUTICALS USA INC. DBA GATE PHARMACEUTICALS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 12.500 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL TABLETS USP 12.5MG 100S PER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00904-4045-60
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505012262924
NSN
6505-01-226-2924
NDC00904-4045-60
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505012262924
NSN
6505-01-226-2924
MFG
MAJOR PHARMACEUTICALS INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 12.500 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL TABLETS USP 12.5MG 100S PER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC49884-0793-01
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505012262924
NSN
6505-01-226-2924
NDC49884-0793-01
CAPTOPRIL TABLETS,USP
NSN, MFG P/N
6505012262924
NSN
6505-01-226-2924
MFG
PAR PHARMACEUTICAL INC.
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 12.500 MILLIGRAMS CAPTOPRIL ACTIVE INGREDIENT
ADMINISTRATION: ORAL
III PART NAME ASSIGNED BY CONTROLLING AGENCY: CAPTOPRIL TABLETS USP 12.5MG 100S PER BOTTLE
PRIMARY CONTAINER CONTENT QUANTITY: 100.000 TABLETS
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
HUMULIN L
INSULIN HUMAN ZINC SUSPENSION,USP
NSN, MFG P/N
6505012262958
NSN
6505-01-226-2958
HUMULIN L
INSULIN HUMAN ZINC SUSPENSION,USP
NSN, MFG P/N
6505012262958
NSN
6505-01-226-2958
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 USP UNITS INSULIN, HUMAN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN ZINC SUSPENSION SUP 100 UNITS PER ML 10ML VIAL
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
III THERAPEUTIC EQUIVALENT: HUMULIN L BY LILLY
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: RECOMBINANT DNA ORIGIN (E.COLI BACTERIA)
Related Searches:
NDC00002-8415-01
INSULIN HUMAN ZINC SUSPENSION,USP
NSN, MFG P/N
6505012262958
NSN
6505-01-226-2958
NDC00002-8415-01
INSULIN HUMAN ZINC SUSPENSION,USP
NSN, MFG P/N
6505012262958
NSN
6505-01-226-2958
MFG
ELI LILLY AND COMPANY DBA ELI LILLY
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 USP UNITS INSULIN, HUMAN PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: INSULIN HUMAN ZINC SUSPENSION SUP 100 UNITS PER ML 10ML VIAL
III PROTECTIVE STORAGE FEATURE: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS
III THERAPEUTIC EQUIVALENT: HUMULIN L BY LILLY
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, MULTIPLE DOSE
SPECIAL FEATURES: RECOMBINANT DNA ORIGIN (E.COLI BACTERIA)
Related Searches:
NDC00074-7650-02
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505012263909
NSN
6505-01-226-3909
NDC00074-7650-02
HEPARIN SODIUM INJECTION,USP
NSN, MFG P/N
6505012263909
NSN
6505-01-226-3909
MFG
ABBOTT LABORATORIES INC. DIV HOSPITAL PRODUCTS DIVISION
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 100.000 UNITS HEPARIN SODIUM PER MILLILITER
PRIMARY CONTAINER CONTENT QUANTITY: 250.000 MILLILITERS
PRIMARY CONTAINER TYPE: BAG, PLASTIC
RAW MATERIAL SOURCE: PORCINE INTESTINAL MUCOSA
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00024-1411-20
IOHEXOL INJECTION,USP
NSN, MFG P/N
6505012265517
NSN
6505-01-226-5517
NDC00024-1411-20
IOHEXOL INJECTION,USP
NSN, MFG P/N
6505012265517
NSN
6505-01-226-5517
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 180.000 MILLIGRAMS IODINE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOHEXOL AND TROMETHAMINE 20ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 20
Related Searches:
NDC00407-1411-20
IOHEXOL INJECTION,USP
NSN, MFG P/N
6505012265517
NSN
6505-01-226-5517
NDC00407-1411-20
IOHEXOL INJECTION,USP
NSN, MFG P/N
6505012265517
NSN
6505-01-226-5517
MFG
GE HEALTH DBA GE HEALTHCARE
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 180.000 MILLIGRAMS IODINE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOHEXOL AND TROMETHAMINE 20ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 20
Related Searches:
OMNIPAQUE 180
IOHEXOL INJECTION,USP
NSN, MFG P/N
6505012265517
NSN
6505-01-226-5517
MFG
SANOFI-SYNTHELABO INC
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 180.000 MILLIGRAMS IODINE PER MILLILITER
III PART NAME ASSIGNED BY CONTROLLING AGENCY: IOHEXOL AND TROMETHAMINE 20ML VIAL 10S
III PROTECTIVE STORAGE FEATURE: SUBJECT TO DAMAGE BY FREEZING
PRIMARY CONTAINER CONTENT QUANTITY: 10.000 MILLILITERS
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: PRESERVATIVE FREE
TOTAL PRIMARY CONTAINER QUANTITY: 20
